Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has reported Q3 FY2026 operational progress across its anti-infective pipeline ...

使用微信扫码将网页分享到微信 很多人喜欢地图。而地图的乐趣，更多在于探索和发现。 Recce 是一个这样的应用，它结合了地理位置及数据处理，同时利用了社交媒体的信息，把你附近状况用 3D 地图呈现出来，它让你有着探索的乐趣，同时，结合应用的各种 ...

Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd has announced its participation in the 2024 Military Health System Research Symposium, where it will present ...

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) says a routine regulatory inspection of one of its Indonesian Phase 3 clinical ...

Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd (ASX:RCE) successfully passed a resolution via poll at their Special General Meeting, marking a significant step ...

While we wait for the full-throttle effect of Apple Maps in iOS6, a new app has launched today that is raising the game for what we should be expecting out of the world of social-mobile-local services ...

Apple CEO Tim Cook apologizedA map application for San Francisco that realizes a 3D map that the map of iPhone 5 aiming is doing is "Recce"is. It is possible to start with iPhone / iPad / iPod Touch.

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has secured a key intellectual property milestone in South America, with Brazil granting a Family 4 patent covering its synthetic anti-infectives ...

Recce, a new film & TV recommendation app designed to cure content overload and bring clarity to viewer decision fatigue, has launched. With an intuitive interface, and a community centric approach, ...

Special Report: Recce Pharmaceuticals has secured patent acceptance in China for its synthetic anti-infectives RECCE® 327 (R327) and RECCE® 529 (R529) as it targets the growing global health problem ...

A$5.0 million commitment received from Australian-based private investor A$10.8 million Entitlement Offer at the same offer price as the placement Funds to support Phase III Topical clinical trials in ...

With COVID-19 vaccines front and centre, the delay announced today appears to be giving this pharmaceutical stock the jitters. According to Recce, overseas studies testing the efficacy of its RECCE ...